A recent warning issued by the Food and Drugs Administration and supported by the American College of Rheumatology Drug Safety Committee draws attention to histoplasmosis and other invasive fungal infections, including fatal cases, reported in RA patients taking TNFα antagonists (FDA Alert 9/4/2008). This evidence concerns the gene TNF and fungal infectious disease.